2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29(7):1303–10.
3. Marshall JC, al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin 2009;25(4):753–68.
4. Ronco C. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Blood Purif 2014;37 Suppl 1:1.
5. Shoji H, Tani T, Hanasawa K, Kodama M. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application. Ther Apher 1998;2(1):3–12.
6. Mitaka C, Tomita M. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock. Shock 2011;36(4):332–8.
7. Maynar J, Martinez-Sagasti F, Herrera-Gutierrez M, Marti F, Candel FJ, Belda J, et al. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: Hemodynamic findings and clinical considerations in anticoagulation therapy. Rev Esp Quimioter 2013;26(2):151–8.
10. Shore S, Nelson DP, Pearl JM, Manning PB, Wong H, Shanley TP, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 2001;88(5):591–4.
11. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA 2009;301(23):2445–52.
12. Tojimbara T, Sato S, Nakajima I, Fuchinoue S, Akiba T, Teraoka S. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure. Ther Apher Dial 2004;8(4):286–92.
13. Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V, et al. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 2010;76(6):405–12.
15. Romaschin AD, Obiezu-Forster CV, Shoji H, Klein DJ. Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion. Blood Purif 2017;44(3):193–7.
16. Takeyama N, Noguchi H, Hirakawa A, Kano H, Morino K, Obata T, et al. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients. Blood Purif 2012;33(4):252–6.
17. Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, et al. Acute kidney injury in patients with sepsis: a contemporary analysis. Int J Infect Dis 2009;13(2):176–81.